We are Roche
A healthier future. It’s what drives us to innovate.
To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come.
Creating a world where we all have more time with the people we love.
That’s what makes us Roche.
In the spotlight
For Investors
Discover great stories aboutSciencePartnershipCulturePatientsSociety
Perspectives and powerful moments that shape healthcare.
We will prevent diseases by identifying high-risk patients early to enable timely use of medicines.
We will stop diseases by accurately diagnosing and stratifying patients to halt disease progression through targeted medicines.
We will cure diseases by identifying the cause of disease in order to restore health through curative medicines.
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Roche Accessibility Statement
At Roche, we are committed to ensuring that our websites and digital resources are accessible to all users.